Assenagon Asset Management S.A.

Position in ZYME — Zymeworks Inc.

CIK 1546007 SENNINGERBERG, N4

Position in ZYME

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$32,727,985

+$14,499,216 QoQ

Shares Held

1,252,027

+72.0% QoQ

Ownership

1.71%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 22 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. ZYME ranks #15 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,727,985	1,252,027	+72.0%	Shares	Sole	2026-07-08
2026-03-31	$18,228,769	727,986	+12.5%	Shares	Sole	2026-04-20
2025-12-31	$17,045,357	647,374	-51.2%	Shares	Sole	2026-01-09
2025-09-30	$22,661,299	1,326,774	+169.2%	Shares	Sole	2025-10-07
2025-06-30	$6,184,389	492,780	-0.5%	Shares	Sole	2025-07-11
2025-03-31	$5,896,247	495,067	-22.9%	Shares	Sole	2025-04-15
2024-12-31	$9,402,554	642,251	+93.9%	Shares	Sole	2025-01-14
2024-09-30	$4,155,857	331,144	+98.8%	Shares	Sole	2024-10-23
2024-03-31	$1,752,095	166,549	—	Shares	Sole	2024-04-24
No filing history on record for this holder in this stock.